Nanopharmaceuticals offer the ability to detect diseases at much earlier stages and the diagnostic applications could build upon conventional procedures using nanoparticles. Nanopharmaceuticals represent an emerging field where the sizes of the drug particle or a therapeutic delivery system work at the Nanoscale. In the pharmaceutical industry, a long-standing issue is the difficulty of delivering the appropriate dose of a particular active agent to a specific disease site. Nanopharmaceuticals have enormous potential in addressing this failure of traditional therapeutics which offers site-specific targeting of active agents. Such precision targeting via Nano pharmaceuticals reduces toxic systemic side effects, resulting in better patient compliance. Today world economy, a pharmaceutical industry faces enormous pressure to deliver high-quality products to patients while maintaining profitability. Therefore pharmaceutical companies are applying nanotechnology to enhance or supplement drug target discovery and drug delivery. Nano pharmaceutical reduces the cost of drug discovery, design & development and enhances the drug delivery process.

  • Track 14-1 Nanoliposome
  • Track 14-2 Drug Targeting
  • Track 14-3Challenges and advances in NanoPharmaceuticals
  • Track 14-4NanoPharmaceuticals from the bench to Scale up
  • Track 14-5Future aspects of NanoPharmaceuticals

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.